Načítá se...
Clinical impact of amotosalen‐ultraviolet A pathogen‐inactivated platelets stored for up to 7 days
BACKGROUND: Universal pathogen inactivation of platelet concentrates (PCs) using amotosalen/ultraviolet A with 7‐day storage was implemented in Switzerland in 2011. Routine‐use data were analyzed at the University Hospital Basel, Switzerland. STUDY DESIGN: A retrospective two‐cohort study of patient...
Uloženo v:
| Vydáno v: | Transfusion |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Inc.
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6900102/ https://ncbi.nlm.nih.gov/pubmed/31574181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.15511 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|